(Q36969178)

17 August 2017

1 reference

title

The adrenal and polycystic ovary syndrome (English)

1 reference

polycystic ovary syndrome

17 August 2017

main subject

1 reference

1 reference

2

Ricardo Azziz

1 reference

ORCID Public Data File 2021

17 August 2017

1 reference

author name string

Bulent O Yildiz

series ordinal

1

1 reference

17 August 2017

language of work or name

1 reference

1 December 2007

1 reference

Reviews in Endocrine and Metabolic Disorders

17 August 2017

published in

1 reference

17 August 2017

volume

8

1 reference

17 August 2017

issue

4

1 reference

17 August 2017

page(s)

331-342

1 reference

Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?

17 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11154-007-9054-0

Increased 5alpha-reductase and normal 11beta-hydroxysteroid dehydrogenase metabolism of C19 and C21 steroids in a young population with polycystic ovarian syndrome

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11154-007-9054-0

Adrenal and ovarian steroid hormone responses to gonadotropin-releasing hormone agonist treatment in polycystic ovary syndrome

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11154-007-9054-0

Increased urinary free cortisol and decreased serum corticosteroid-binding globulin in polycystic ovary syndrome

21 January 2018

1 reference

12 December 2020

Endogenous inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 do not explain abnormal cortisol metabolism in polycystic ovary syndrome

1 reference

12 December 2020

Hyperandrogenism in carriers of CYP21 mutations: the role of genotype

1 reference

12 December 2020

Aromatization of Androstenedione to Estrone by Human Adipose Tissue in Vitro. Correlation with Adipose Tissue Mass, Age, and Endometrial Neoplasia*

1 reference

12 December 2020

Hyperinsulinemia and circulating dehydroepiandrosterone sulfate in white and Mexican American women with polycystic ovary syndrome

1 reference

12 December 2020

The hormonal phenotype of Nonclassic 3 beta-hydroxysteroid dehydrogenase (HSD3B) deficiency in hyperandrogenic females is associated with insulin-resistant polycystic ovary syndrome and is not a variant of inherited HSD3B2 deficiency

1 reference

12 December 2020

Is the inappropriate gonadotropin secretion of patients with polycystic ovary syndrome similar to that of patients with adult-onset congenital adrenal hyperplasia?

1 reference

12 December 2020

Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS).

1 reference

12 December 2020

Newly proposed hormonal criteria via genotypic proof for type II 3beta-hydroxysteroid dehydrogenase deficiency

1 reference

12 December 2020

1 reference

12 December 2020

Studies on changes in the concentration of serum adrenal androgens in pubertal twins

1 reference

12 December 2020

The prevalence and significance of elevated dehydroepiandrosterone sulfate levels in anovulatory women

1 reference

12 December 2020

Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis

1 reference

12 December 2020

The effect of 17 beta-estradiol on adrenocortical sensitivity, responsiveness, and steroidogenesis in postmenopausal women

1 reference

12 December 2020

Adrenocortical secretion of dehydroepiandrosterone in healthy women: highly variable response to adrenocorticotropin

1 reference

12 December 2020

Adrenal androgen excess in hyperandrogenism: relation to age and body mass

1 reference

12 December 2020

Adrenal 21-hydroxylase gene mutations in Slovenian hyperandrogenic women: evaluation of corticotrophin stimulation and HLA polymorphisms in screening for carrier status

1 reference

12 December 2020

Adrenocortical hyperfunction in idiopathic hirsutism and the Stein-Leventhal syndrome

1 reference

12 December 2020

Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism

1 reference

12 December 2020

Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis

1 reference

12 December 2020

Adrenal steroids in post-menopausal women: relation to obesity and to bone mineral content

1 reference

12 December 2020

Correlation of adrenocorticotropin steroid levels between women with polycystic ovary syndrome and their sisters

1 reference

12 December 2020

Effect of obesity on the response to acute adrenocorticotropin stimulation in eumenorrheic women

1 reference

12 December 2020

Intraadrenal interactions in the regulation of adrenocortical steroidogenesis.

1 reference

12 December 2020

Evidence for the Importance of Peripheral Tissue Events in the Development of Hirsutism in Polycystic Ovary Syndrome*

1 reference

12 December 2020

Role of a CYP17 polymorphism in the regulation of circulating dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome

1 reference

12 December 2020

Clinical and biological phenotypes in late-onset 21-hydroxylase deficiency

1 reference

12 December 2020

Hyperandrogenism in polycystic ovary syndrome. Evidence of dysregulation of 11 beta-hydroxysteroid dehydrogenase

1 reference

12 December 2020

Aromatization of androstenedione by human adipose tissue stromal cells in monolayer culture

1 reference

12 December 2020

11beta-hydroxyandrostenedione and delta5-androstenediol as markers of adrenal androgen production in patients with 21-hydroxylase-deficient nonclassic adrenal hyperplasia

1 reference

12 December 2020

Corticosteroid-binding globulin and unbound serum cortisol in women with polycystic ovary syndrome

1 reference

12 December 2020

5 alpha-reductase activity in polycystic ovary syndrome

1 reference

12 December 2020

The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans

1 reference

12 December 2020

Androgen parameters and their correlation with body weight in one hundred thirty-eight women thought to have hyperandrogenism

1 reference

12 December 2020

Endocrine consequences of premature pubarche in post-pubertal Caucasian girls

1 reference

12 December 2020

Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess

1 reference

12 December 2020

Abnormalities of 21-hydroxylase gene ratio and adrenal steroidogenesis in hyperandrogenic women with an exaggerated 17-hydroxyprogesterone response to acute adrenal stimulation

1 reference

12 December 2020

Ovarian suppression reduces clinical and endocrine expression of late-onset congenital adrenal hyperplasia due to 21-hydroxylase deficiency

1 reference

12 December 2020

Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women

1 reference

12 December 2020

Clinical review 56: Nonclassic adrenal hyperplasia: current concepts

1 reference

12 December 2020

Overexpression of mouse follistatin causes reproductive defects in transgenic mice.

1 reference

12 December 2020

Increased DHEAs levels in PCO syndrome: evidence for the existence of two subgroups of patients

1 reference

12 December 2020

Troglitazone decreases adrenal androgen levels in women with polycystic ovary syndrome

1 reference

12 December 2020

Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism

1 reference

12 December 2020

Androgen response to endogenous insulin secretion during the frequently sampled intravenous glucose tolerance test in normal and hyperandrogenic women

1 reference

12 December 2020

Stability of adrenocortical steroidogenesis over time in healthy women and women with polycystic ovary syndrome

1 reference

12 December 2020

Impact of architectural disruption on adrenocortical steroidogenesis in vitro.

1 reference

12 December 2020

Dehydroepiandrosterone Sulfate (DS) Levels, a Rapid Test for Abnormal Adrenal Androgen Secretion

1 reference

12 December 2020

Pituitary-adrenal responses to ovine corticotropin-releasing factor in polycystic ovary syndrome and in other hyperandrogenic patients

1 reference

12 December 2020

The Effects of Prolonged Hypertestosteronemia on Adrenocortical Biosynthesis in Oophorectomized Women*

1 reference

12 December 2020

The hypothalamo-pituitary-adrenal axis across the normal menstrual cycle and in polycystic ovary syndrome

1 reference

12 December 2020

Long-term administration of gonadotropin-releasing hormone agonist and dexamethasone: assessment of the adrenal role in ovarian dysfunction

1 reference

12 December 2020

The role of adrenal hyperandrogenism, insulin resistance, and obesity in the pathogenesis of polycystic ovarian syndrome.

1 reference

12 December 2020

Elevated dehydroepiandrosterone sulfate levels as the reproductive phenotype in the brothers of women with polycystic ovary syndrome.

1 reference

12 December 2020

Heritability of dehydroepiandrosterone sulfate in women with polycystic ovary syndrome and their sisters

1 reference

12 December 2020

Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism

1 reference

12 December 2020

A variant of the glucocorticoid receptor gene is not associated with adrenal androgen excess in women with polycystic ovary syndrome

1 reference

12 December 2020

Molecular abnormalities of the 21-hydroxylase gene in hyperandrogenic women with an exaggerated 17-hydroxyprogesterone response to short-term adrenal stimulation

1 reference

12 December 2020

Dehydroepiandrosterone sulfate as an indicator of adrenal androgen function

1 reference

12 December 2020

The prevalence and features of the polycystic ovary syndrome in an unselected population

1 reference

12 December 2020

24-hour serum cortisol profiles in women with polycystic ovary syndrome

1 reference

12 December 2020

Secretion of major adrenal androgens following ACTH administration in obese women with different body fat distribution.

1 reference

12 December 2020

The role of heterozygosity for CYP21 in the polycystic ovary syndrome

1 reference

12 December 2020

Heritability of variation of plasma cortisol levels

1 reference

12 December 2020

The cincinnati myocardial infarction and hormone family study: Family resemblance for dehydroepiandrosterone sulfate in control and myocardial infarction families

1 reference

12 December 2020

21-Hydroxylase–deficient nonclassic adrenal hyperplasia is a progressive disorder: A multicenter study

1 reference

12 December 2020

Effects of metformin on adrenal steroidogenesis in women with polycystic ovary syndrome

1 reference

12 December 2020

A genetic component to the variation of dehydroepiandrosterone sulfate

1 reference

12 December 2020

Thiazolidinediones but not metformin directly inhibit the steroidogenic enzymes P450c17 and 3beta -hydroxysteroid dehydrogenase

1 reference

12 December 2020

Genes for enzymes regulating dehydroepiandrosterone sulfonation are associated with levels of dehydroepiandrosterone sulfate in polycystic ovary syndrome

1 reference

12 December 2020

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

1 reference

12 December 2020

Abnormalities of the hypothalamic-pituitary-adrenal axis in nondepressed women with abdominal obesity and relations with insulin resistance: evidence for a central and a peripheral alteration

1 reference

12 December 2020

Effect of pioglitazone treatment on the adrenal androgen response to corticotrophin in obese patients with polycystic ovary syndrome.

1 reference

12 December 2020

Acth function in women with the polycystic ovarian syndrome

1 reference

12 December 2020

Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance

1 reference

12 December 2020

Longitudinal changes in dehydroepiandrosterone concentrations in men and women

1 reference

12 December 2020

Glucose action and adrenocortical biosynthesis in women with polycystic ovary syndrome

1 reference

12 December 2020

Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline

1 reference

12 December 2020

Role of the ovary in the adrenal androgen excess of hyperandrogenic women

1 reference

12 December 2020

Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates

1 reference

12 December 2020

Follow-up study of adolescent girls with a history of premature pubarche

1 reference

12 December 2020

Chediak-Higashi syndrome in pregnancy

1 reference

12 December 2020

Hyperandrogenism and manifesting heterozygotes for 21-hydroxylase deficiency

1 reference

12 December 2020

Identification of virilizing adrenal tumors in hirsute women

1 reference

12 December 2020

Ovine corticotropin-releasing factor and dexamethasone responses in hyperandrogenic women.

1 reference

12 December 2020

Competitive reverse transcription-polymerase chain reaction analysis indicates that levels of aromatase cytochrome P450 transcripts in adipose tissue of buttocks, thighs, and abdomen of women increase with advancing age

1 reference

12 December 2020

CYP11B1 mutations causing non-classic adrenal hyperplasia due to 11 beta-hydroxylase deficiency

1 reference

12 December 2020

Cortisol metabolism in human obesity: impaired cortisone-->cortisol conversion in subjects with central adiposity

1 reference

12 December 2020

Testosterone, Dehydroepiandrosterone, and Dehydroepiandrosterone Sulfate in Hyperandrogenic Women

1 reference

12 December 2020

Relative sensitivity and responsivity of serum cortisol and two adrenal androgens to alpha-adrenocorticotropin-(1-24) in normal and obese, nonhirsute, eumenorrheic women

1 reference

12 December 2020

Carrier status for steroid 21-hydroxylase deficiency is only one factor in the variable phenotype of acne

1 reference

12 December 2020

Serum dehydroepiandrosterone sulfate levels as an individual marker

1 reference

12 December 2020

Beyond adrenal and ovarian androgen generation: Increased peripheral 5 alpha-reductase activity in women with polycystic ovary syndrome

1 reference

12 December 2020

Girls diagnosed with premature pubarche show an exaggerated ovarian androgen synthesis from the early stages of puberty: evidence from gonadotropin-releasing hormone agonist testing

1 reference

12 December 2020

Influence of insulin and testosterone on adrenocortical steroidogenesis in vitro: preliminary studies

1 reference

12 December 2020

Polycystic Ovary Syndrome

1 reference

12 December 2020

Adrenocortical hyperresponsiveness to corticotropin in polycystic ovary syndrome patients with adrenal androgen excess

1 reference

12 December 2020

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

1 reference

12 December 2020

10.1007/S11154-007-9054-0

Identifiers

DOI

1 reference

17 August 2017

1 reference